Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-08-28

Clinical Trial Update: FDG Uptake in Vaginal Tampons is Due to Urine [NA]

View source ↗

Summary

A completed clinical trial investigating FDG uptake in vaginal tampons, concluded to be due to urine rather than tumor activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Irene Burger | Conditions: Cancer | NA | Status: COMPLETED | Results posted: 2019-08-28